Media coverage
1
Media coverage
Title HCRN investigators report switch maintenance pembrolizumab leads to additional objective responses, prolongs progression-free survival in some patients with metastatic urothelial cancer Media name/outlet India Pharma News Country/Territory India Date 27/06/20 Persons Matthew Galsky